- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Homatropine is a medication used to treat gastrointestinal disorders. It is a type of anticholinergic drug, which works by blocking the action of acetylcholine, a neurotransmitter that is involved in the regulation of smooth muscle contraction. Homatropine is used to treat conditions such as irritable bowel syndrome, gastritis, and peptic ulcers. It is also used to reduce the symptoms of motion sickness, such as nausea and vomiting. Homatropine is available in both oral and injectable forms.
Homatropine is a widely used medication in the gastrointestinal drug market. It is often prescribed as a first-line treatment for gastrointestinal disorders, due to its effectiveness and low risk of side effects. It is also used in combination with other medications to treat more severe conditions.
Some companies in the Homatropine market include Pfizer, Merck, and Novartis. Show Less Read more